Germany’s signing of the 2010 G8 Muskoka Initiative elevated child health and with it immunisation to a stronger level of priority. Chancellor Merkel’s 2014 response to Ebola, confirming global health within the nation’s development policy, was followed by Germany’s G7 and G20 Presidencies in 2015 and 2017. They firmly anchored global health in the country’s politics, including in the current Coalition Treaty. Germany, Ghana and Norway’s April 2018 request to global health actors to establish an Global Action Plan for Healthy Lives and Well-Being for All put health at the centre of the SDGs.
As patron of Gavi’s replenishment conference in Berlin in January 2015, Chancellor Merkel pledged EUR 600 million for Gavi over the 2016-2020 strategic period – an impressive milestone in Germany’s history of increasing its support for Gavi, the Vaccine Alliance.
In late 2010, Germany increased its 2011 contribution to EUR 6 million on an initiative by the German Federal Parliament. In April 2011, the Development Minister committed an additional contribution of EUR 14 million to Gavi for as part of the Muskoka Initiative, bringing the donor’s 2011 contribution to EUR 20 million. May 2011 then saw a 2012 commitment of EUR 30 million from Germany, preceding the 2013 Vaccine Summit in Abu Dhabi which marked Germany’s first multi-year commitment to Gavi by a pledge of an additional EUR 90 million for Gavi over 2013-2015.
Note: Proceeds are funds made available to Gavi from donor contributions and commitments, either through cash payments made to Gavi, through frontloading via the capital markets of a future donor commitment to IFFIm, or through AMC funds released to Gavi via the World Bank. IFFIm proceeds are allocated over five year periods coinciding with Gavi’s strategic periods. Proceeds for the current and future strategic periods are indicative until the end of each period and could be revised following changes in market conditions (interest rates or foreign exchange rates), the signing of new pledge(s) and/or changes in IFFIm’s disbursement profile.
Click on Direct, IFFIm, AMC or Matching Fund in the above key to toggle their data on the graph, click again to show the data
Direct Contributions (including Matching Fund)
Received contributions: non-US$ contributions for 2000-2018 and Q1-Q3 2019 are expressed in US$ equivalents using the exchange rates on the dates of receipt. For 2014-2018 and Q1-Q3 2019, where contributions were hedged to mitigate currency risk exposure, these have been expressed using the rates applicable to the hedge agreement.
Future contributions: non-US$ Direct Contribution and Matching Fund pledges for Q4 2019 and years 2020 and beyond are expressed in US$ equivalents using the applicable 'forecast rates' from Bloomberg as at 30 September 2019 or using the rates applicable to any hedge agreement in place.
Received contributions: non-US$ contributions for 2000-2018 and Q1-Q3 2019 are expressed in US$ equivalents as confirmed by the IBRD (World Bank)
Future contributions: non-US$ contributions for Q4 2019 and years 2020 and beyond are expressed in US$ equivalents as follows:
Where the contribution agreement has been signed: contributions are expressed in US$ equivalents using the exchange rates at the time of signing the respective donor grant agreements
Where the contribution agreement has not yet been signed: contributions are expressed in US$ equivalents using the applicable 'forecast rates' from Bloomberg as at 30 September 2019
While IFFIm grants are irrevocable and legally binding, they are subject to a Grant Payment Condition that can potentially reduce the amount due in the event that a programme country is in protracted arrears with the International Monetary Fund. As of 30 September 2019, IFFIm donor grant payments are reduced by 1.5%, however such reductions are not reflected in future contributions figures.
A Gavi donor since 2006, Germany contributes to Gavi through direct contributions via both, the Federal Ministry for Economic Cooperation and Development (BMZ) and KfW Development Bank and represents its Constituency Group as 2019 Gavi Board Member following its 2018 Alternate Board Member role.
Germany’s rights-based health for development approach pivots around maternal, newborn and child health, prevention of communicable diseases, strengthening of and support for health systems as well as sustainability and stakeholder alignment. It thus aligns very well with The Vaccine Alliance’s mandate and business model.
Contributions and pledges in total: